BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10668421)

  • 1. Role of glycemia in acute spinal cord injury. Data from a rat experimental model and clinical experience.
    Sala F; Menna G; Bricolo A; Young W
    Ann N Y Acad Sci; 1999; 890():133-54. PubMed ID: 10668421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hyperglycemia on progressive paraparesis in a rat etastatic spinal tumor model.
    McGirt MJ; Gok B; Shepherd S; Noggle J; Garcés Ambrossi GL; Bydon A; Gokaslan ZL
    J Neurosurg Spine; 2009 Jan; 10(1):9-15. PubMed ID: 19119926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylprednisolone reduces spinal cord injury in rats without affecting tumor necrosis factor-alpha production.
    Taoka Y; Okajima K; Uchiba M; Johno M
    J Neurotrauma; 2001 May; 18(5):533-43. PubMed ID: 11393256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of arterial blood gas values on lesion volumes in a graded rat spinal cord contusion model.
    Huang PP; Young W
    J Neurotrauma; 1994 Oct; 11(5):547-62. PubMed ID: 7861447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal cord injuries in older children: is there a role for high-dose methylprednisolone?
    Arora B; Suresh S
    Pediatr Emerg Care; 2011 Dec; 27(12):1192-4. PubMed ID: 22158284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of postinjury treatment with methylprednisolone or tirilazad mesylate on the increase in eicosanoid levels in the acutely injured cat spinal cord.
    Hall ED; Yonkers PA; Taylor BM; Sun FF
    J Neurotrauma; 1995 Jun; 12(3):245-56. PubMed ID: 7473799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons learned from administration of high-dose methylprednisolone sodium succinate for acute pediatric spinal cord injuries.
    Caruso MC; Daugherty MC; Moody SM; Falcone RA; Bierbrauer KS; Geis GL
    J Neurosurg Pediatr; 2017 Dec; 20(6):567-574. PubMed ID: 28984538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lactic acidosis: a complication of spinal cord injury in multiple trauma].
    Hasse W; Weidtmann A; Voeltz P
    Unfallchirurg; 2000 Jun; 103(6):495-8. PubMed ID: 10925653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postischemic hyperglycemia worsens neurologic outcome after spinal cord ischemia.
    Hemmila MR; Zelenock GB; D'Alecy LG
    J Vasc Surg; 1993 Apr; 17(4):661-8. PubMed ID: 8464083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of early surgical decompression on functional and histological outcomes after severe experimental thoracic spinal cord injury.
    Jalan D; Saini N; Zaidi M; Pallottie A; Elkabes S; Heary RF
    J Neurosurg Spine; 2017 Jan; 26(1):62-75. PubMed ID: 27636866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic time window for methylprednisolone in spinal cord injured rat.
    Yoon DH; Kim YS; Young W
    Yonsei Med J; 1999 Aug; 40(4):313-20. PubMed ID: 10487132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of high dose methylprednisolone on cell apoptosis and Bcl-2 expression after acute spinal cord injuries in rats].
    Ma LJ; Zhang JJ; Wu HT
    Zhongguo Gu Shang; 2009 Sep; 22(9):692-3. PubMed ID: 19817205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End organ effects of high-dose human equivalent methylprednisolone in a spinal cord injury rat model.
    Kubeck JP; Merola A; Mathur S; Brkaric M; Majid K; Shanti N; Caruso S; Yuan S; Lowe T; Dwyer A; Haher T; O'Brien M
    Spine (Phila Pa 1976); 2006 Feb; 31(3):257-61. PubMed ID: 16449896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological interventions for acute spinal cord injury.
    Bracken MB
    Cochrane Database Syst Rev; 2000; (2):CD001046. PubMed ID: 10796741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance in tetraplegia but not in mid-thoracic paraplegia: is the mid-thoracic spinal cord involved in glucose regulation?
    Bluvshtein V; Korczyn AD; Pinhas I; Vered Y; Gelernter I; Catz A
    Spinal Cord; 2011 May; 49(5):648-52. PubMed ID: 21042331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of Neuroprotection Against Experimental Spinal Cord Injury by Riluzole or Methylprednisolone.
    Sámano C; Nistri A
    Neurochem Res; 2019 Jan; 44(1):200-213. PubMed ID: 29290040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy is activated in injured neurons and inhibited by methylprednisolone after experimental spinal cord injury.
    Chen HC; Fong TH; Lee AW; Chiu WT
    Spine (Phila Pa 1976); 2012 Mar; 37(6):470-5. PubMed ID: 21587101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study.
    Bracken MB; Shepard MJ; Holford TR; Leo-Summers L; Aldrich EF; Fazl M; Fehlings M; Herr DL; Hitchon PW; Marshall LF; Nockels RP; Pascale V; Perot PL; Piepmeier J; Sonntag VK; Wagner F; Wilberger JE; Winn HR; Young W
    JAMA; 1997 May; 277(20):1597-604. PubMed ID: 9168289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose methylprednisolone in the management of acute spinal cord injury - a systematic review from a clinical perspective.
    Short DJ; El Masry WS; Jones PW
    Spinal Cord; 2000 May; 38(5):273-86. PubMed ID: 10822400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biochemical effectiveness of N-acetylcysteine in experimental spinal cord injury in rats.
    Hanci V; Kerimoğlu A; Koca K; Başkesen A; Kiliç K; Taştekin D
    Ulus Travma Acil Cerrahi Derg; 2010 Jan; 16(1):15-21. PubMed ID: 20209390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.